Sensus Healthcare Q4 record revenue $13.0M, EPS $0.32; FY 2021 revenue $27.0M up 182%

Sensus Healthcare, Inc.

2021-FY EPS reported $0.25 revenue$27,042,000

Q4 revenue $13.0M (+156% YoY); net income $5.3M ($0.32 diluted EPS) vs $1.0M ($0.06) in Q4 2020.
Full-year 2021 revenue $27.0M (+182%); diluted EPS $0.25 vs loss of $0.42 in 2020.
Shipped record 35 systems in Q4, including 3 to China; received Ministry of Health license renewal through 2026.
Signed exclusive U.S. distribution agreement for TransDermal Infusion System for needle-less drug delivery.
Affirms expectation for Q1 2022 continued growth and full-year 2022 profitability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.